Trial RBR-95yjmq
Publication Rodrigues C, Int J Antimicrob Agents, 2021
Primary outcome on the report: Time (days) to viral clearance within a 9-day evaluation period following enrollment following the onset of symptoms and the study enrollment dates.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.